Anemia, Diabetes, and Chronic Kidney Disease
Open Access
- 1 July 2009
- journal article
- review article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7), 1320-1326
- https://doi.org/10.2337/dc08-0779
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Iron Indices in Chronic Kidney Disease in the National Health and Nutritional Examination Survey 1988–2004Clinical Journal of the American Society of Nephrology, 2009
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesKidney International, 2008
- NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis PatientsSeminars in Dialysis, 2008
- Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical dataNephrology Dialysis Transplantation, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseThe New England Journal of Medicine, 2006
- Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT studyClinical Nephrology, 2005
- Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney diseaseAmerican Heart Journal, 2005
- Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care OrganizationArchives of Internal Medicine, 2004
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997
- Urinary albumin, transferrin and iron excretion in diabetic patientsKidney International, 1991